These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37440274)

  • 1. Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and
    Ruan X; Zhang X; Liu L; Zhang J
    J Biomol Struct Dyn; 2024 Jul; 42(10):5128-5146. PubMed ID: 37440274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.
    Wu WZ; Ling-Hu T; Zhao YH; Zhao WD; Ji C; Tian JS; Ren Y; Qin XM
    J Ethnopharmacol; 2023 Jan; 300():115702. PubMed ID: 36099982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of Xiaoyao San in treatment of depression,breast hyperplasia,and functional dyspepsia based on network pharmacology].
    Wei FX; Liu HL; Fan YH; Li XQ; Zhao SJ; Qin XM; Liu XJ
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4230-4237. PubMed ID: 34467737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
    Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
    J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.
    Yang S; Wei Z; Luo J; Wang X; Chen G; Guan X; She Z; Liu W; Tong Y; Liu H; Wen M; Chen H; Zhu P; Li G; Wang D; Huang L; Xu S; Chen D; Zhang Q; Wei Y
    Phytomedicine; 2024 Sep; 132():155834. PubMed ID: 38941818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
    Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte steatosis activates macrophage inflammatory response accelerating atherosclerosis development.
    Li Y; Wu X; Pan J; Gong L; Min D
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):751-765. PubMed ID: 38105677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
    Liu X; Wei F; Liu H; Zhao S; Du G; Qin X
    J Ethnopharmacol; 2021 Mar; 268():113549. PubMed ID: 33152435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Xiao-Yao-San in the Treatment of Inflammatory Response in CUMS Mice.
    Zhang Y; Li XJ; Wang XR; Wang X; Li GH; Xue QY; Zhang MJ; Ao HQ
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice.
    Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y
    J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway.
    Xu Y; Chen W; Chen Z; Huang M; Yang F; Zhang Y
    Drug Des Devel Ther; 2021; 15():753-767. PubMed ID: 33654381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
    Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
    J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
    Yang J; Ma W; Mei Q; Song J; Shu L; Zhang S; Li C; An L; Du N; Shi Z
    Biol Pharm Bull; 2020; 43(11):1626-1633. PubMed ID: 33132309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
    Li S; Wu X; Ma Y; Zhang H; Chen W
    J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
    Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q
    J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Xiaoyao San on exercise capacity and liver mitochondrial metabolomics in rat depression model.
    Zhao W; Ji C; Zheng J; Zhou S; Tian J; Han Y; Qin X
    Chin Herb Med; 2024 Jan; 16(1):132-142. PubMed ID: 38375048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
    Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
    J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyretic effects of Xiangqin Jiere granules on febrile young rats revealed by combining pharmacodynamics, metabolomics, network pharmacology, molecular biology experiments and molecular docking strategies.
    He X; Cui J; Li H; Zhou Y; Wu X; Jiang C; Xu Z; Wang R; Xiong L
    J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38197809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.